Shelley Bausch
appointed Shelley Bausch to serve as a Class II director of the Company starting as of July 1, 2026
Highest-materiality recent filing
Innospec appoints Shelley Bausch to Board and Audit Committee effective July 1, 2026
Board expanded from 7 to 8 directors; Bausch appointed as Class II director through 2027 annual meeting.
Innospec shareholders re-elect two Class I directors, approve executive compensation
Shareholders re-elected Elizabeth K. Arnold (19.3M for) and Claudia P. Poccia (19.7M for) as Class I directors.
Innospec Q1 revenue $453.2M (+3% YoY); adjusted EPS $1.05 vs $1.42; dividend raised 10% to $0.92
GAAP EPS $1.22, net income $30.4M; adjusted non-GAAP EPS $1.05 (both down YoY).
Innospec reports Q4 GAAP EPS $1.91, adjusted EPS $1.50; revenue $455.6M
Net income $47.4M ($1.91 diluted) vs net loss $70.4M ($2.80 loss) last year, which included UK pension buyout.
Innospec Q3 EPS $0.52 GAAP ($1.12 adj), down from $1.33; impairments of $42.9M; dividend +10%
Revenue $441.9M flat YoY; net income $12.9M vs $33.4M; adjusted EBITDA $44.2M vs $50.5M.
Innospec Q2 2025: Revenue $439.7M (+1% YoY); GAAP EPS $0.94, adjusted EPS $1.26, net cash $266.6M
Q2 revenue $439.7M (+1% YoY); GAAP net income $23.5M ($0.94 EPS) vs $31.2M ($1.24 EPS) last year.
David F. Landless, Lawrence J. Padfield, and Patrick S. Williams elected with 21.7M–22.4M votes for each.
Innospec Q1 revenue $440.8M (-12% YoY); GAAP EPS $1.31, adj EPS $1.42; dividend +10%
Net income $32.8M ($1.31 diluted EPS) vs $41.4M ($1.65) a year ago; adjusted EPS $1.42 vs $1.75.
Innospec board approves $50M buyback over 3 years; net cash $289M
Board authorized repurchase of up to $50M in common stock over three years starting March 10, 2025.
Innospec Q4 GAAP loss $2.80 on $155.6M pension charge; adjusted EPS $1.41
GAAP net loss of $70.4M ($2.80 per share) driven by $155.6M non-cash UK pension buyout settlement charge.
Innospec Q3 revenue $443M (-4% YoY), EPS $1.33, dividend raised 10% to $1.55 annual
Revenue $443.4M, down 4% YoY from $464.1M; net income $33.4M vs $39.2M; GAAP EPS $1.33, adjusted $1.35.
Innospec Q2: rev $435M (-9% YoY), GAAP EPS $1.24, adj EPS $1.39, net cash $240M
Q2 revenue $435M (-9% YoY); net income $31.2M ($1.24 diluted EPS) vs $28.9M ($1.16) prior year.
Innospec extends $250M multicurrency revolver maturity to May 2028
May 16, 2024: lenders approved extension of $250M revolving facility from May 2027 to May 31, 2028.
Innospec shareholders elect directors, approve say-on-pay and auditor at annual meeting
Election of Milton C. Blackmore with 22,508,064 for, 578,796 withheld.
Innospec Q1 revenue $500.2M (-2%); GAAP EPS $1.65, adjusted $1.75; dividend up 10%
GAAP EPS $1.65 vs $1.33; adjusted non-GAAP EPS $1.75 vs $1.38; net income $41.4M vs $33.2M.
Innospec EVP & COO Philip Boon to retire effective March 31, 2025; will serve as consultant
Philip Boon, Executive Vice President and COO, notified Innospec of his decision to retire effective March 31, 2025.
Innospec Q4 net income up 48% to $37.8M; adjusted EPS $1.84 beats prior year $1.20
Revenue $494.7M (-3% YoY); net income $37.8M ($1.51 diluted) vs $25.5M ($1.02) last year.
Innospec completes acquisition of Brazilian specialty chemicals company QGP Química Geral
Acquired QGP, a Brazilian specialty chemicals firm with 300 employees, for undisclosed terms.
Innospec Q3 revenue down 10% to $464.1M; EPS $1.57; annual dividend increased 10%
Revenue $464.1M vs $513.0M last year, down 10%; net income $39.2M ($1.57 diluted EPS).
Innospec Q2 revenue up 3% to $480.4M; net income falls to $28.9M on $8M Brazil exit charge
GAAP EPS $1.16 vs $1.29 a year ago; adjusted non-GAAP EPS $1.28 vs $1.58.
Innospec closes new $250M multicurrency revolving credit facility, replacing 2019 bank facility
Four-year unsecured facility matures May 30, 2027, with option to extend one year at Company's discretion.
Innospec director Robert Paller will not stand for re-election at 2024 Annual Meeting
Robert Paller informed Innospec on May 8, 2023 of his decision not to stand for re-election.
Innospec shareholders elect two Class I directors and approve say-on-pay frequency of 1 year
Claudia P. Poccia elected with 20,015,816 for (2,989,917 withheld); Elizabeth K. Arnold with 22,406,421 for (599,312 withheld).
Innospec reports Q1 revenue up 8% to $509.6M; GAAP EPS $1.33, adjusted EPS $1.38
Revenue $509.6M (+8% YoY) driven by strong Oilfield Services growth.
Innospec Q4 revenue up 24% to $510.7M; adjusted EPS $1.20 vs $1.30 YoY; net cash $147.1M
Q4 revenue $510.7M (+24% YoY); net income $25.5M ($1.02 diluted EPS) vs $23.9M ($0.96) last year.
Innospec posts updated corporate presentation on its website
Presentation dated December 2022 posted on Investors section of innospec.com.
Innospec Q3 revenue up 36% to $513M; adjusted EPS $1.74 vs $1.15; dividend raised 10%
Revenue $513.0M, +36% YoY; net income $38.7M ($1.55 EPS) vs $23.4M ($0.94).
Innospec Q2 2022 revenue up 32% to $467.6M; adjusted EPS $1.58 vs $1.30 last year
GAAP EPS of $1.29 ($32.3M net income) versus $0.90 in Q2 2021.
Innospec shareholders elect directors, approve say-on-pay, ratify auditor
David F. Landless elected with 22,503,235 votes for; 541,013 withheld.
Innospec Q1 revenue up 39% to $472.4M; adjusted EPS $1.53; dividend increased 11%
Revenue $472.4M (+39% YoY); net income $36.5M ($1.46 diluted EPS) vs $23.4M ($0.94)
Innospec Q4 revenues up 33% to $413M; GAAP EPS $0.96, adjusted EPS $1.30; announces $50M buyback
Q4 revenues $413.2M (+33% YoY); GAAP diluted EPS $0.96, adjusted non-GAAP EPS $1.30.
Innospec appoints Leslie J. Parrette as non-employee director, board expands to eight
Leslie J. Parrette appointed to Innospec's Board as Class II director, effective Jan 1, 2022.
Innospec Q3 revenue up 42% to $376.1M; adj. EPS $1.15; annual dividend raised 12% to $1.16
Revenue $376.1M (+42% YoY); net income $23.4M ($0.94 GAAP EPS) vs $12.7M ($0.51) last year.
Innospec Q2 revenue up 45% to $354.5M; adjusted EPS $1.30 vs loss year ago
Revenue $354.5M (+45% YoY); net income $22.4M ($0.90 EPS) vs loss of $39.7M a year ago.
appointed Shelley Bausch to serve as a Class II director of the Company starting as of July 1, 2026
On March 31, 2024, Dr. Philip Boon, Executive Vice President and Chief Operating Officer of Innospec Inc. (the “Company”), informed the Company of his decision to officially retire effective March 31, 2025.
On May 8, 2023, Robert Paller, a member of the Board of Directors (the “Board”) of Innospec Inc. (the “Company”), informed the Company of his decision not to stand for re-election to the Board when his current term as a director expires at the Company’s 2024 Annual Meeting of Stockholders (“Annual Meeting”).
appointed Mr. Leslie J. Parrette to serve as a Class II director of the Company until the 2022 annual meeting of stockholders of the Company.
Max materiality 0.75 · Median 0.65 · Most common event earnings